We are a Level II OHP (Out of Hospital Premise) approved by the College of Physicians and Surgeons of Ontario for administering intravenous medications for Major Depression and Refractory Depression

​

Our centre has undergone the OHP approval process with all policies, procedures, staff training, equipment, and approaches having been reviewed and approved to ensure they meet the safety standards of the College of Physicians and Surgeons of Ontario. 

​

Certain intravenous medications can provide benefit for patients with indicated conditions, but it is important to know that it must be administered in an appropriate setting with physicians that have experience with the medication. 

​

Referral Process

​

For intravenous treatment in mood disorders our centre requires that patients have an active psychiatrist involved in their care to make an eligibility assessment. We collaborate with academic psychiatrists that assess and monitor patients before and during therapy. For referring psychiatrists that are comfortable with NMDA antagonists for MDD and would like to continue to care for their patients during treatment, contact our centre as we offer an affiliation pathway for psychiatrists.

​

Price for Treatment

​

For non-OHIP covered conditions fee information is available directly from the clinic. All treatments are delivered in a safe and regulatory compliant manner with the appropriate equipment, specialists, and follow-up. ​

​

Drugs with Benefit in Mood Conditions: 

​

In accordance with Health Canada section 70 of the Narcotics Control Regulations, specific drugs cannot be listed on a public website. Please contact your psychiatrist further information.